P. Jordaan

发表

Analysis of Unipolar Electrograms in Rabbit Heart Demonstrated the Key Role of Ventricular Apicobasal Dispersion in Arrhythmogenicity

N. Guérard, P. Jordaan, B. Dumotier, 2014, Cardiovascular Toxicology.

Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials.

S. Jackson, Kathryn L Chapman, J. Valentin, 2016, Regulatory toxicology and pharmacology : RTP.

Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056).

E. Voltz, R. Woessner, E. Legangneux, 2016, Clinical therapeutics.

Detecting asymptomatic coronary artery disease using routine exercise testing and exercise thallium scintigraphy in patients with atherosclerotic vascular disease.

A. Otto, P. Jordaan, C. Nel, 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Direct and rapid inhibition of factor Xa by otamixaban: A pharmacokinetic and pharmacodynamic investigation in patients with coronary artery disease

A. Frick, P. Jordaan, Jochen Maas, 2006, Clinical pharmacology and therapeutics.

Autonomic correlates of late infarct artery patency after first myocardial infarction.

J. Camm, M. Malik, T. Farrell, 1993, American Heart Journal.

Assessment of Drug Interaction Potential between LCZ696, an Angiotensin Receptor Neprilysin Inhibitor, and Digoxin or Warfa rin

Ra, P. Pal, T. Langenickel, 2015 .

Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.

D. Atar, H. Krum, P. Jordaan, 2015, International journal of cardiology.

Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects

P. Jordaan, Priya Chandra, J. Flarakos, 2016, Xenobiotica; the fate of foreign compounds in biological systems.

Abstract 19378: First Experience with Concomitant AT1 and Neprilysin (NEP 24.11) Inhibition with LCZ696 in Patients with Chronic Heart Failure

P. Jordaan, Priya Chandra, Z. Kobalava, 2010 .

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

P. Pal, T. Langenickel, I. Rajman, 2016, European Journal of Clinical Pharmacology.

Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization

P. Pal, T. Langenickel, I. Rajman, 2016, European Journal of Clinical Pharmacology.

Pharmacokinetics of Pipamperone from Three Different Tablet Formulations

R. Schall, P. Jordaan, H. Hundt, 2002, Arzneimittelforschung.

Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

D. Atar, H. Krum, P. Jordaan, 2015, Circulation. Heart failure.

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction

P. Pal, T. Langenickel, I. Rajman, 2016, Cardiovascular therapeutics.

Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single-center, phase I, randomized, four-way crossover study

P. Jordaan, K. Hu, Astrid Breitschaft, 2013, Journal of clinical pharmacology.

Abstract 448: Assessment of Drug Interaction Potential Between LCZ696 and Warfarin

P. Pal, T. Langenickel, G. Sunkara, 2013, HYPERTENSION.

Comparing QT interval variability of semiautomated and high‐precision ECG methodologies in seven thorough QT studies—implications for the power of studies intended for definitive evaluation of a drug's QT effect

B. Darpo, P. Jordaan, Karin Meiser, 2017, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes.

Paul E. Miller, L. Urban, P. Jordaan, 2021, Toxicological sciences : an official journal of the Society of Toxicology.

Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies

G. Muscogiuri, P. Jordaan, A. Colao, 2017, Endocrine.

LCZ696, an angiotensin receptor neprilysin inhibitor, attenuates renal fibrosis after myocardial infarction and reduces angiotensin-II-mediated renal cellular collagen synthesis

D. Atar, H. Krum, P. Jordaan, 2015 .

Analysis of Unipolar Electrograms in Rabbit Heart Demonstrated the Key Role of Ventricular Apicobasal Dispersion in Arrhythmogenicity

N. Guérard, P. Jordaan, B. Dumotier, 2014, Cardiovascular Toxicology.

The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors

H. Hurwitz, Sunil Sharma, P. Jordaan, 2019, Cancer Chemotherapy and Pharmacology.

A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat

S. Vormfelde, E. Legangneux, C. Kolly, 2020, Clinical and translational science.

Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.

D. Atar, H. Krum, P. Jordaan, 2015, International journal of cardiology.

Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

D. Atar, H. Krum, P. Jordaan, 2015, Circulation. Heart failure.